Exact Mass: 426.192
Exact Mass Matches: 426.192
Found 301 metabolites which its exact mass value is equals to given mass value 426.192
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Cariprazine
D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014150 - Antipsychotic Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants C78272 - Agent Affecting Nervous System > C29710 - Antipsychotic Agent N - Nervous system > N05 - Psycholeptics > N05A - Antipsychotics Cariprazine is a novel antipsychotic agent candidate that exhibits high affinity for the D3 (Ki=0.085 nM) and D2 (Ki=0.49 nM) receptors, and moderate affinity for the 5-HT1A receptor (Ki=2.6 nM).
11,13-Dihydrotaraxinic acid glucosyl ester
Constituent of Taraxacum officinale (dandelion). 11,13-Dihydrotaraxinic acid glucosyl ester is found in many foods, some of which are tea, alcoholic beverages, coffee and coffee products, and dandelion. 11,13-Dihydrotaraxinic acid glucosyl ester is found in alcoholic beverages. 11,13-Dihydrotaraxinic acid glucosyl ester is a constituent of Taraxacum officinale (dandelion)
(2,3-Dihydro-5-methyl-3-((4-morpholinyl)methyl)pyrrolo-(1,2,3-de)-1,4-benzoxazin-6-yl)(1-naphthalenyl)methanone monomethanesulfonate
Gemfibrozil 1-O-beta-Glucuronide
Iloperidone
D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014150 - Antipsychotic Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants C78272 - Agent Affecting Nervous System > C29710 - Antipsychotic Agent N - Nervous system > N05 - Psycholeptics > N05A - Antipsychotics Iloperidone (HP 873) is a D2/5-HT2 receptor antagonist. Iloperidone is an atypical antipsychotic for the schizophrenia symptoms[1][2].
Mespirenone
Ripisartan
Sonchuside E
(5-methyl-3-(morpholinomethyl)-2,3-dihydro-[1,4]oxazino[2,3,4-hi]indol-6-yl)(naphthalen-1-yl)methanone
D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002317 - Cardiovascular Agents > D002121 - Calcium Channel Blockers D002491 - Central Nervous System Agents > D000700 - Analgesics D000077264 - Calcium-Regulating Hormones and Agents D049990 - Membrane Transport Modulators
3-O-beta-D-glucopyranosyl-3beta,14-dihydroxycostunolide
7beta-O-beta-glucopyranosyl bombaxone|7beta-O-beta-glucopyranosyl-10beta-hydroxy hibiscone B
10beta,14-dihydroxy-10(14),11beta(13)-tetrahydro-8,9-didehydro-3-deoxyzaluzanin C-10-O-beta-glucopyranoside
8beta-hydroxy-4alpha,15-dihydrozaluzanin C-3-O-beta-glucopyranoside
(1R,5R,6R,7S,9R)-6,9alpha-epoxy-9,15-bisabolanolide-5-O-beta-D-glucopyranoside|abiespiroside A
(3S)-3-hydroxyatractylenolide III 3-O-beta-D-glucopyranoside|(3S)-3-Hydroxyatractylenolide III 3-O-??-D-glucopyranoside|(3S,5R,8R,10R)-3,8-dihydroxyeudesma-4(15),7(11)-diene-8,12-olide 3-O-beta-D-glucopyranoside
cynarascoloside C|isoamberboin 8-O-beta-D-glucopyranoside
4alpha-O-beta-D-glucopyranosyl-15-hydroxyl-5alpha,6betaH-guaiane-10(14),11(13)-dien-12,6alpha-olide
13,17-epoxy-1beta,11beta,12alpha,14beta,15beta-pentahydroxy-2alpha-methoxypicras-3-en-16-one|bruceine M
11,13-dihydro-taraxinic acid 14-O-beta-D-glucoside|11,13-Dihydro-Taraxinsaeure-1-O-beta-D-Glucopyranosid|11,13-dihydrotaraxinic acid-beta-glucopyranosyl ester|11beta,13-dihydrotaraxinic acid beta-glucopyranosyl ester|11??,13-Dihydro-taraxinic acid-1-O-??-D-glucopyranoside
1(10)E-4Z-3alpha-hydroxy-germacra-1(10),4,11(13)-trien-6,12-olide-14-O-beta-D-glucopyranoside
11beta,13-dihydrodesacylcynaropicrin 8-beta-D-glucoside|11beta,13-dihydrodesacylcynaropicrin-8-beta-D-glucoside|11betaH-11,13-dihydrodesacylcynaropicrin 8-beta-D-glucoside|3beta-hydroxy-11beta,13-dihydro-8alpha-O-beta-D-glucozaluzanin C
(2R,3R)-pterosin L 3-O-beta-D-glucopyranoside|2R,3R-pterosin L 3-O-beta-D-glucopyranoside
15-glucopyranosyloxy-2-oxo-guai-3-en-1alpha,5alpha,6beta,7a,10alpha,11betaH-12,6-olide
4alpha-hydroxy-5alpha,8betaH-lindan-7(11)-en-8alpha,12-olide-15-O-beta-D-glucopyranoside|sarcaglaboside G
ABA-GE cpd
(+)-abscisic acid beta-D-glucopyranosyl ester is a (+)-abscisic acid D-glucopyranosyl ester that is derived from beta-D-glucopyranose. It is functionally related to a (+)-abscisic acid and a beta-D-glucose. (+)-abscisic acid beta-D-glucopyranosyl ester is a natural product found in Salacia chinensis, Arabidopsis thaliana, and other organisms with data available. D020011 - Protective Agents > D000975 - Antioxidants > D002338 - Carotenoids
[5-formyl-4,8-dihydroxy-3-(3-methoxy-3-oxoprop-1-en-2-yl)-8a-methyl-2,3,4,4a,5,6,7,8-octahydro-1H-naphthalen-2-yl] 3,4-dihydroxy-2-methylidenebutanoate
C21H30O9_Azuleno[4,5-b]furan-2(3H)-one, 8-(beta-D-glucopyranosyloxy)decahydro-6-hydroxy-6-methyl-3,9-bis(methylene)-, (3aS,6R,6aR,8S,9aR,9bS)
[5-formyl-4,8-dihydroxy-3-(3-methoxy-3-oxoprop-1-en-2-yl)-8a-methyl-2,3,4,4a,5,6,7,8-octahydro-1H-naphthalen-2-yl] 3,4-dihydroxy-2-methylidenebutanoate
[5-formyl-4,8-dihydroxy-3-(3-methoxy-3-oxoprop-1-en-2-yl)-8a-methyl-2,3,4,4a,5,6,7,8-octahydro-1H-naphthalen-2-yl] 3,4-dihydroxy-2-methylidenebutanoate_major
Ala Ala Glu His
Ala Ala His Glu
Ala Glu Ala His
Ala Glu His Ala
Ala His Ala Glu
Ala His Glu Ala
Asp Gly His Val
Asp Gly Val His
Asp His Gly Val
Asp His Val Gly
Asp Val Gly His
Asp Val His Gly
Glu Ala Ala His
Glu Ala His Ala
Glu His Ala Ala
Phe Phe Gly Gly
Phe Gly Gly Phe
Gly Asp His Val
Gly Asp Val His
Gly Phe Phe Gly
Gly Phe Gly Phe
Gly Gly Phe Phe
Gly His Asp Val
Gly His Val Asp
Gly Val Asp His
Gly Val His Asp
His Ala Ala Glu
His Ala Glu Ala
His Asp Gly Val
His Asp Val Gly
His Glu Ala Ala
His Gly Asp Val
His Gly Val Asp
His Pro Ser Ser
His Ser Pro Ser
His Ser Ser Pro
His Val Asp Gly
His Val Gly Asp
Pro His Ser Ser
Pro Ser His Ser
Pro Ser Ser His
Ser His Pro Ser
Ser His Ser Pro
Ser Pro His Ser
Ser Pro Ser His
Ser Ser His Pro
Ser Ser Pro His
Val Asp Gly His
Val Asp His Gly
Val Gly Asp His
Val Gly His Asp
Val His Asp Gly
Val His Gly Asp
Win 55212-2
A organic heterotricyclic compound that is 5-methyl-3-(morpholin-4-ylmethyl)-2,3-dihydro[1,4]oxazino[2,3,4-hi]indole substituted at position 6 by a 1-naphthylcarbonyl group. D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002317 - Cardiovascular Agents > D002121 - Calcium Channel Blockers D002491 - Central Nervous System Agents > D000700 - Analgesics D000077264 - Calcium-Regulating Hormones and Agents D049990 - Membrane Transport Modulators
Phe Gly Phe Gly
11,13-Dihydrotaraxinic acid glucosyl ester
3H-Indolium, 1,3,3-trimethyl-2-[2-(1-methyl-2-phenyl-1H-indol-3-yl)ethenyl]-, chloride (1:1)
2-acetamido-3-o-benzyl-4,6-o-benzylidene-2-deoxy-beta-d-glucopyranosyl azide
Ripisartan
C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent > C66930 - Angiotensin II Receptor Antagonist
Methanesulfonamide, N-(3-(3-((2,3-dihydro-2-hydroxy-1H-inden-2-yl)methyl)-6-ethyl-3-azabicyclo(3.1.0)hex-6-yl)phenyl)-
Methanone, (2,3-dihydro-5-methyl-3-(4-morpholinylmethyl)pyrrolo(1,2,3-de)-1,4-benzoxazin-6-yl)-1-naphthalenyl-, (S)-
D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002317 - Cardiovascular Agents > D002121 - Calcium Channel Blockers D002491 - Central Nervous System Agents > D000700 - Analgesics D000077264 - Calcium-Regulating Hormones and Agents D049990 - Membrane Transport Modulators
4-[2-(3-Hydroxyphenyl)ethyl]-2-[4-[2-(3-hydroxyphenyl)ethyl]phenoxy]phenol
Iloperidone
D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014150 - Antipsychotic Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants C78272 - Agent Affecting Nervous System > C29710 - Antipsychotic Agent N - Nervous system > N05 - Psycholeptics > N05A - Antipsychotics Iloperidone (HP 873) is a D2/5-HT2 receptor antagonist. Iloperidone is an atypical antipsychotic for the schizophrenia symptoms[1][2].
5-methyl-3-[3-[4-[2-(2,2,2-trifluoroethoxy)phenyl]piperazin-1-yl]propyl]-1H-pyrimidine-2,4-dione
D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists
(S)-2-trans-abscisic acid beta-D-glucopyranosyl ester
An (S)-2-trans-abscisic acid D-glucopyranosyl ester derived from beta-D-glucopyranose.
1-O-[(2E,4E)-5-(1-hydroxy-2,6,6-trimethyl-4-oxocyclohex-2-en-1-yl)-3-methylpenta-2,4-dienoyl]-D-glucopyranose
N-[(2S,3R,4R,5S,6R)-2-[(2R,3S,4R,5S)-5-Acetamido-1,2,4,6-tetrahydroxyhexan-3-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]acetamide
2-[(3S,6aS,8R,10aS)-3-hydroxy-1-(1-oxopropyl)-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-[(3,5-difluorophenyl)methyl]acetamide
2-[(3R,6aR,8R,10aR)-3-hydroxy-1-(1-oxopropyl)-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-[(3,5-difluorophenyl)methyl]acetamide
2-[(3R,6aS,8S,10aS)-3-hydroxy-1-(1-oxopropyl)-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-[(3,5-difluorophenyl)methyl]acetamide
2-[(3S,6aR,8R,10aR)-3-hydroxy-1-(1-oxopropyl)-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-[(3,5-difluorophenyl)methyl]acetamide
[(2S,3R)-6-(benzenesulfonyl)-1-(cyclopentylmethyl)-3-phenyl-1,6-diazaspiro[3.3]heptan-2-yl]methanol
2-[(3R,6aS,8R,10aS)-3-hydroxy-1-(1-oxopropyl)-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-[(3,5-difluorophenyl)methyl]acetamide
2-[(3S,6aS,8S,10aS)-3-hydroxy-1-(1-oxopropyl)-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-[(3,5-difluorophenyl)methyl]acetamide
2-[(3S,6aR,8S,10aR)-3-hydroxy-1-(1-oxopropyl)-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-[(3,5-difluorophenyl)methyl]acetamide
2-[(3R,6aR,8S,10aR)-3-hydroxy-1-(1-oxopropyl)-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-[(3,5-difluorophenyl)methyl]acetamide
[(2S,3S)-6-(benzenesulfonyl)-1-(cyclopentylmethyl)-3-phenyl-1,6-diazaspiro[3.3]heptan-2-yl]methanol
[(2R,3R)-6-(benzenesulfonyl)-1-(cyclopentylmethyl)-3-phenyl-1,6-diazaspiro[3.3]heptan-2-yl]methanol
(S)-2-trans-abscisic acid D-glucopyranosyl ester
A carboxylic ester that results from the condensation of the carboxylic acid group of (S)-2-trans-abscisic acid with the anomeric hydroxy group of D-glucopyranose.
N-[(3R,4R,5S,6R)-2-[(2R,3R,4R,5S)-5-Acetamido-2,3,4,6-tetrahydroxyhexoxy]-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]acetamide
2-trans-abscisic acid D-glucosyl ester
An enoate ester that results from the condensation of the carboxylic acid group of 2-trans-abscisic acid with the anomeric hydroxy group of D-glucopyranose.
Etrumadenant
Etrumadenant (AB928) is an orally bioavailable, selective dual adenosine receptor (A2aR/A2bR) antagonist. Etrumadenant relieves adenosine-mediated immune suppression. Etrumadenant has immunomodulatory and antitumor activities[1][2].
His-[D-2-ME-Trp]-Ala
His-[D-2-ME-Trp]-Ala is a fragment of the growth hormone hexarelin.
3-hydroxy-3-methyl-6,9-dimethylidene-8-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-octahydroazuleno[4,5-b]furan-2-one
3,10-dimethyl-2-oxo-9-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3h,3ah,4h,5h,8h,9h,11ah-cyclodeca[b]furan-6-carbaldehyde
(2r,3r)-6-(2-hydroxyethyl)-2-(hydroxymethyl)-2,5,7-trimethyl-3-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3h-inden-1-one
(3r,3ar,6ar,8s,9ar,9br)-3-hydroxy-3-methyl-6,9-dimethylidene-8-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-octahydroazuleno[4,5-b]furan-2-one
4-[2-(2-hydroxyphenyl)ethyl]-2-{4-[2-(3-hydroxyphenyl)ethyl]phenoxy}phenol
5a-methyl-3-methylidene-2-oxo-6-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-octahydro-3ah-naphtho[1,2-b]furan-9-carbaldehyde
4-[2-(3-hydroxyphenyl)ethyl]-2-{4-[2-(3-hydroxyphenyl)ethyl]phenoxy}phenol
3-methyl-2-oxo-10-{[(3,4,5-trihydroxy-6-methoxyoxan-2-yl)oxy]methyl}-3h,3ah,4h,5h,8h,9h,11ah-cyclodeca[b]furan-6-carbaldehyde
4-hydroxy-3,6-dimethyl-9-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)-3h,3ah,4h,5h,7h,9ah,9bh-azuleno[4,5-b]furan-2-one
(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl (3s,3as,11as)-3,10-dimethyl-2-oxo-3h,3ah,4h,5h,8h,9h,11ah-cyclodeca[b]furan-6-carboxylate
(3as,5ar,6s,7r,9as,9bs)-7-hydroxy-5a,9-dimethyl-3-methylidene-6-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3ah,4h,5h,6h,7h,9ah,9bh-naphtho[1,2-b]furan-2-one
(3as,6r,6ar,8s,9ar,9bs)-6-hydroxy-6-methyl-3,9-dimethylidene-8-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-octahydroazuleno[4,5-b]furan-2-one
(2r)-2-[(2s,3s)-8-methyl-3-({[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}carbonyl)-1,2,3,5,6,7-hexahydronaphthalen-2-yl]propanoic acid
(2s)-4-hydroxy-6-(2-hydroxyethyl)-2,5,7-trimethyl-2-({[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)-3h-inden-1-one
6-(hydroxymethyl)-3-methyl-9-methylidene-6-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3h,3ah,6ah,7h,8h,9ah,9bh-azuleno[4,5-b]furan-2-one
9-hydroxy-9-methyl-3,6-dimethylidene-8-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-octahydroazuleno[4,5-b]furan-2-one
3-methyl-5-(2,6,6-trimethyl-4-oxo-1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}cyclohex-2-en-1-yl)penta-2,4-dienoic acid
(1r,3r,4s,9s,16s,18s,19r,21s)-16-(hydroxymethyl)-13-methoxy-12,20-dimethyl-11,14-dioxo-5-oxa-8,17,20-triazahexacyclo[15.3.1.0³,¹⁹.0⁴,⁸.0⁹,¹⁸.0¹⁰,¹⁵]henicosa-10(15),12-diene-21-carbonitrile
(3s,3as,9r,11as)-3,10-dimethyl-2-oxo-9-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3h,3ah,4h,5h,8h,9h,11ah-cyclodeca[b]furan-6-carbaldehyde
10β,14-dihydroxy-10(14),11β(13)-tetrahydro-8,9-didehydro-3-deoxyzaluzanin c10-o-β-d-glucopyranoside
{"Ingredient_id": "HBIN000060","Ingredient_name": "10\u03b2,14-dihydroxy-10(14),11\u03b2(13)-tetrahydro-8,9-didehydro-3-deoxyzaluzanin c10-o-\u03b2-d-glucopyranoside","Alias": "NA","Ingredient_formula": "C21H30O9","Ingredient_Smile": "CC1C2C=CC(C3CCC(=C)C3C2OC1=O)(CO)OC4C(C(C(C(O4)CO)O)O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "6142","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
1(10),4,11(13)-germacratrien-12,6-olid-14-oic acid; (1(10)z,4e,6α)-form,11,13-dihydro,beta-d-glucopyranosyl ester
{"Ingredient_id": "HBIN000218","Ingredient_name": "1(10),4,11(13)-germacratrien-12,6-olid-14-oic acid; (1(10)z,4e,6\u03b1)-form,11,13-dihydro,beta-d-glucopyranosyl ester","Alias": "NA","Ingredient_formula": "C21H30O9","Ingredient_Smile": "NA","Ingredient_weight": "0","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "9728","PubChem_id": "NA","DrugBank_id": "NA"}
11β,13-dihydrotaraxinic acid
{"Ingredient_id": "HBIN000361","Ingredient_name": "11\u03b2,13-dihydrotaraxinic acid","Alias": "NA","Ingredient_formula": "C21H30O9","Ingredient_Smile": "CC1C2CCC(=CCCC(=CC2OC1=O)C)C(=O)OC3C(C(C(C(O3)CO)O)O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "41594","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
11β,13-dihydro-taraxinicacid-1'-o-β-d-glucopyranoside
{"Ingredient_id": "HBIN000362","Ingredient_name": "11\u03b2,13-dihydro-taraxinicacid-1'-o-\u03b2-d-glucopyranoside","Alias": "NA","Ingredient_formula": "C21H30O9","Ingredient_Smile": "CC1C2C(CC(=C)C3CC(C(=C)C3C2OC1=O)O)OC4C(C(C(C(O4)CO)O)O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "5723","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
11β,13-dihydrotaraxinic acid β-glucopyranosyl ester
{"Ingredient_id": "HBIN000363","Ingredient_name": "11\u03b2,13-dihydrotaraxinic acid \u03b2-glucopyranosyl ester","Alias": "NA","Ingredient_formula": "C21H30O9","Ingredient_Smile": "CC1C2CCC(=CCCC(=CC2OC1=O)C)C(=O)OC3C(C(C(C(O3)CO)O)O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "41595","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
2r,3r-pterosin l-2'-o-β-d-glucoside
{"Ingredient_id": "HBIN006457","Ingredient_name": "2r,3r-pterosin l-2'-o-\u03b2-d-glucoside","Alias": "NA","Ingredient_formula": "C21H30O9","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "18126","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
2s,3r-pterosin l-2'-o-β-d-glucoside
{"Ingredient_id": "HBIN006686","Ingredient_name": "2s,3r-pterosin l-2'-o-\u03b2-d-glucoside","Alias": "NA","Ingredient_formula": "C21H30O9","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "18127","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
(3s)-3-hydroxyatractylenolide iii3-o-β-d-glucopyranoside
{"Ingredient_id": "HBIN009613","Ingredient_name": "(3s)-3-hydroxyatractylenolide iii3-o-\u03b2-d-glucopyranoside","Alias": "NA","Ingredient_formula": "C21H30O9","Ingredient_Smile": "CC1=C2CC3C(=C)C(CCC3(CC2(OC1=O)O)C)OC4C(C(C(C(O4)CO)O)O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "9805","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
9α-hydroxy-11β,13-dihydrozaluzanin c3-o-β-allopyranoside
{"Ingredient_id": "HBIN014042","Ingredient_name": "9\u03b1-hydroxy-11\u03b2,13-dihydrozaluzanin c3-o-\u03b2-allopyranoside","Alias": "NA","Ingredient_formula": "C21H30O9","Ingredient_Smile": "CC1C2CC(C(=C)C3CC(C(=C)C3C2OC1=O)OC4C(C(C(C(O4)CO)O)O)O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "10011","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}